Fibrin-fibrinogen degradation products in cerebrospinal fluid.

Coagulation and fibrinolytic activity of cerebrospinal fluid. J Clin Pathol (1978) 0.98

Proteomic analysis of cerebrospinal fluid in pneumococcal meningitis reveals potential biomarkers associated with survival. J Infect Dis (2010) 0.89

Fibrin degradation products in the cerebrospinal fluid of patients with pneumococcal meningitis. J Neurol Neurosurg Psychiatry (1979) 0.78

Childhood bacterial meningitis. J Neurol Neurosurg Psychiatry (1982) 0.75

The fibrin plate method for estimating fibrinolytic activity. Arch Biochem Biophys (1952) 9.50

Quantitative estimation of split products of fibrinogen in human serum, relation to diagnosis and treatment. Blood (1966) 6.49

New one-stage procedures for the quantitative determination of prothrombin and labile factor. Am J Clin Pathol (1950) 1.58

Antifibrinolytic therapy for intracranial aneurysms. J Neurosurg (1968) 1.48

Fibrin degradation products in the serum and cerebrospinal fluid of patients with group A meningococcal meningitis. J Clin Pathol (1974) 1.47

Pathogenesis of intraventricular haemorrhage in newborn infants. Arch Dis Child (1974) 1.40

A technique for routine evaluation of plasminogen in humans during streptokinase therapy. Acta Haematol (1965) 1.09

Angiographic manifestations in cerebral inflammatory disease. Radiology (1971) 1.07

Fibrinolysis and subarachnoid haemorrhage. Inhibitory effect of tranexamic acid. A clinical study. Acta Neurol Scand (1972) 1.02

Fibrin-fibrinogen degradation products in cerebrospinal fluid of patients admitted to a psychiatric unit. J Neurol Neurosurg Psychiatry (1974) 0.99

Use of an anti-fibrinolytic agent (tranexamic acid) in the management of ruptured intracranial aneurysms. Postgrad Med J (1971) 0.98

Effect of mental stress on the fibrinolytic reactivity to exercise. Br Med J (1967) 0.95

Arteriographic demonstration of vascular lesions in the study of neurologic deficit in advanced Haemophilus influenzae meningitis. Dev Med Child Neurol (1972) 0.87

Detection of fibrinogen antigens with two latex techniques applied to urine concentrates. J Clin Pathol (1973) 0.84

Urinary fibrin-fibrinogen degradation products in nephrotic syndrome. Br Med J (1975) 0.83

Early treatment with parenteral penicillin in meningococcal disease. BMJ (1992) 6.82

Efficacy of tests used to monitor rheumatoid arthritis. Lancet (1989) 2.50

Automated measurement of plasma viscosity by capillary viscometer. J Clin Pathol (1988) 2.48

Epidemiology and clinical management of meningococcal disease in west Gloucestershire: retrospective, population based study. BMJ (1997) 2.31

Intraepithelial, lamina propria and Peyer's patch lymphocytes of the rat small intestine: isolation and characterization in terms of immunoglobulin markers and receptors for monoclonal antibodies. Immunology (1982) 2.15

Encephalopathy in acute leukaemia associated with methotrexate therapy. Arch Dis Child (1972) 1.93

Medical student concentration during lectures. Lancet (1978) 1.93

A new host gene (groPC) necessary for lambda DNA replication. Mol Gen Genet (1977) 1.91

What mothers say about why poor children fall behind on immunizations. A summary of focus groups in North Carolina. Arch Pediatr Adolesc Med (1995) 1.88

Serial study of C-reactive protein during infection in leukaemia. J Clin Pathol (1981) 1.79

A retrospective survey of clusters of meningococcal disease in England and Wales, 1993 to 1995: estimated risks of further cases in household and educational settings. Commun Dis Rep CDR Rev (1997) 1.76

Evaluation of a drama-in-education programme to increase AIDS awareness in South African high schools: a randomized community intervention trial. Int J STD AIDS (2000) 1.74

Screening for abnormal haemoglobins: a pilot study. Br Med J (1973) 1.72

Monitoring the acute phase response. BMJ (1988) 1.69

Recurrent abdominal pain and Helicobacter pylori in a community-based sample of London children. Acta Paediatr (1996) 1.68

Gestational age assessment in Nigerian newborn infants. Arch Dis Child (1973) 1.67

C-reactive protein for rapid diagnosis of infection in leukaemia. J Clin Pathol (1979) 1.66

Haemophilia A home therapy in the United Kingdom 1975-6. Br Med J (1978) 1.61

Increased resting energy expenditure in cystic fibrosis. J Appl Physiol (1985) (1988) 1.49

Hyperviscosity and thrombotic changes in idiopathic and secondary Raynaud's syndrome. Br J Haematol (1980) 1.47

Fibrin degradation products in the serum and cerebrospinal fluid of patients with group A meningococcal meningitis. J Clin Pathol (1974) 1.47

Structural analysis of BAG1 cochaperone and its interactions with Hsc70 heat shock protein. Nat Struct Biol (2001) 1.43

Selective inhibition of FAAH produces antidiarrheal and antinociceptive effect mediated by endocannabinoids and cannabinoid-like fatty acid amides. Neurogastroenterol Motil (2013) 1.43

Improving prospects for employment of the haemophiliac. Br Med J (1980) 1.43

Evaluation of the intraepithelial lymphocyte count in the jejunum in childhood enteropathies. Gut (1976) 1.37

Complement activation in children with acute malaria. Clin Exp Immunol (1974) 1.37

C-reactive protein concentration as a guide to antibiotic therapy in acute leukaemia. J Clin Pathol (1982) 1.35

Haemorrhagic episodes in haemophilia: a 5-year prospective study. Br Med J (1966) 1.33

Invasive Haemophilus influenzae disease in adults. Epidemiol Infect (2000) 1.32

Consumption coagulopathy in congenital heart-disease. Lancet (1973) 1.28

Sympathetic ophthalmia in Canada. Can J Ophthalmol (1972) 1.26

An improved chromogenic substrate endotoxin assay for clinical use. J Clin Pathol (1983) 1.25

Serum levels of acute phase and cardiac proteins after myocardial infarction, surgery, and infection. Br Heart J (1982) 1.25

Capillary-blood coagulation profile in the newborn. Lancet (1973) 1.23

From concept to application: the impact of a community-wide intervention to improve the delivery of preventive services to children. Pediatrics (2001) 1.23

Subclinical ischaemic episodes during the steady state of sickle cell anaemia. J Clin Pathol (1992) 1.18

Invasive meningococcal disease among university undergraduates: association with universities providing relatively large amounts of catered hall accommodation. Epidemiol Infect (1999) 1.17

Hepatic dysfunction in association with pancreatic insufficiency and cyclical neutropenia. Shwachman-Diamond syndrome. Arch Dis Child (1977) 1.17

Thrombolytic therapy in haemolytic--uraemic syndrome. Br Med J (1974) 1.14

Allergic bronchopulmonary aspergillosis complicating cystic fibrosis in childhood. Arch Dis Child (1980) 1.13

Serial changes in coagulation and viscosity during sickle-cell crisis. Br J Haematol (1979) 1.13

Induction of siderophore activity in Anabaena spp. and its moderation of copper toxicity. Appl Environ Microbiol (1987) 1.13

Sodium bicarbonate prophylaxis of sickle cell crisis. Pediatrics (1974) 1.13

Haematological stress syndrome in atherosclerosis. J Clin Pathol (1981) 1.12

Mathematical modelling of infection and disease due to Neisseria meningitidis and Neisseria lactamica. Int J Epidemiol (2000) 1.12

Efficiency of haematological screening tests for detecting disease. Clin Lab Haematol (1981) 1.11

Improving preventive service delivery through office systems. Pediatrics (2001) 1.11

Evaluation of sealed vacuum extraction method (Seditainer) for measurement of erythrocyte sedimentation rate. J Clin Pathol (1989) 1.11

Erythrocyte deformability in sickle-cell crisis. Br J Haematol (1981) 1.11

Ranking of laboratory tests by consensus analysis. Lancet (1986) 1.09

The cytocentrifuge NBT test. J Clin Pathol (1975) 1.09

Outbreak of Escherichia coli O157 infection associated with a music festival. Eur J Clin Microbiol Infect Dis (1999) 1.09

Acquisition and carriage of meningococci in marine commando recruits. Epidemiol Infect (1998) 1.09

Blood rheology. J Clin Pathol (1980) 1.06

Sodium valproate and platelet function. Br Med J (1976) 1.06

Haemophilia and the kidney: assessment after 11-year follow-up. Br Med J (Clin Res Ed) (1982) 1.06

Effect of BW12C on oxygen affinity of haemoglobin in sickle-cell disease. Lancet (1986) 1.06

Epidermal growth factor in necrotising enteritis. Lancet (1991) 1.05

X-ray reporting in accident and emergency departments--reducing errors. Eur J Emerg Med (1997) 1.05

Thrombocytosis of active rheumatoid disease. Ann Rheum Dis (1983) 1.05

Nitrendipine is a potent inhibitor of the Ca(2+)-activated K+ channel of human erythrocytes. FEBS Lett (1992) 1.05

A cytochemical study of marrow enzymes in megaloblastic anaemia. Br J Haematol (1968) 1.04

Receptor-mediated endocytosis of albumin by kidney proximal tubule cells is regulated by phosphatidylinositide 3-kinase. J Clin Invest (1998) 1.04

Invasive pneumococcal infection in South and West England. Epidemiol Infect (1998) 1.03

Platelet hyperactivity in sickle-cell disease: a consequence of hyposplenism. J Clin Pathol (1980) 1.02

Effect of alpha thalassaemia on the rheology of homozygous sickle cell disease. Br J Haematol (1983) 1.02

Quantitative enzyme cytochemistry of leukaemic cells. J Clin Pathol (1969) 1.00

Severe neurological damage associated with methotrexate therapy. Lancet (1971) 1.00

Rheological analysis of the adhesive interactions of red blood cells parasitized by Plasmodium falciparum. Blood (1992) 0.99

Coagulation fibrinolysis in sickle-cell disease. J Clin Pathol (1974) 0.99

Erythrocyte rheology. J Clin Pathol (1985) 0.99

Capillary blood collection in haematology. J Clin Pathol (1974) 0.98

Cell clusters in the nucleus accumbens of the rat, and the mosaic relationship of opiate receptors, acetylcholinesterase and subcortical afferent terminations. Neuroscience (1984) 0.98

Blood rheology and proliferative retinopathy in sickle cell-haemoglobin C disease. Br J Ophthalmol (1984) 0.98

Coagulation and fibrinolytic activity of cerebrospinal fluid. J Clin Pathol (1978) 0.98

Effect of polymerization tendency on haematological, rheological and clinical parameters in sickle cell anaemia. Br J Haematol (1989) 0.96

Treatment of acute anaphylaxis. Chart helps with calculation of dose of adrenaline for children. BMJ (1995) 0.95

Preservation of deformability (filterability) of sickle cells by BW12C during progressive deoxygenation. Br J Haematol (1983) 0.94

Rheological changes in the prodromal and established phases of sickle cell vaso-occlusive crisis. Br J Haematol (1992) 0.94

The role of PCR in the diagnosis and management of CMV in solid organ recipients: what is the predictive value for the development of disease and should PCR be used to guide antiviral therapy? Transplantation (1997) 0.93

Pharmacological modification of oxygen affinity improves deformability of deoxygenated sickle erythrocytes: a possible therapeutic approach to sickle cell disease. Clin Sci (Lond) (1989) 0.92

Neutrophil cytochemistry in bacterial infection. J Clin Pathol (1979) 0.91

Kinetic effect of human lactoferrin on the growth of Escherichia coli 0111. Int J Biochem (1984) 0.91

Endotoxaemia as a cause of fever in immunosuppressed patients. J Clin Pathol (1984) 0.91

Autonomic dysfunction in tetanus - what lessons can be learnt with specific reference to alpha-2 agonists? Anaesthesia (2007) 0.91

Rheology of the sickle cell disorders. Baillieres Clin Haematol (1987) 0.91

Energy and nutrient intakes in cystic fibrosis. Arch Dis Child (1989) 0.90

Blood rheology and proliferative retinopathy in homozygous sickle cell disease. Br J Ophthalmol (1986) 0.90

Haemostatic and rheological changes in normal pregnancy and pre-eclampsia. Br J Haematol (1982) 0.90

Ancrod in sickle-cell crisis. Lancet (1972) 0.90

C reactive protein rapid assay techniques for monitoring resolution of infection in immunosuppressed patients. J Clin Pathol (1984) 0.90

Optimising oral rehydration solution composition in model systems: studies in normal mammalian small intestine. Acta Paediatr Scand Suppl (1989) 0.90

Influence of age and carriage status on salivary IgA to Neisseria meningitidis. Epidemiol Infect (2005) 0.89

Fluctuating deformability of oxygenated sickle erythrocytes in the asymptomatic state and in painful crisis. Br J Haematol (1985) 0.89

Anaemic crisis in sickle cell disease. J Clin Pathol (1975) 0.88